Shares of athenahealth, Inc (NASDAQ:ATHN) have earned an average recommendation of “Hold” from the twenty-eight ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, seventeen have given a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $141.76.

Several research firms have weighed in on ATHN. KeyCorp reiterated a “buy” rating and issued a $152.00 price objective on shares of athenahealth in a research note on Friday. Citigroup began coverage on shares of athenahealth in a research note on Thursday, January 4th. They issued a “neutral” rating on the stock. Oppenheimer reiterated a “buy” rating and issued a $184.00 price objective on shares of athenahealth in a research note on Friday, October 20th. Canaccord Genuity reiterated a “hold” rating and issued a $123.00 price objective (down previously from $144.00) on shares of athenahealth in a research note on Monday, October 23rd. Finally, BidaskClub upgraded shares of athenahealth from a “strong sell” rating to a “sell” rating in a research note on Saturday, December 2nd.

In related news, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction on Friday, October 20th. The shares were sold at an average price of $130.00, for a total value of $104,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Bradford Kyle Armbrester sold 1,000 shares of the firm’s stock in a transaction on Friday, October 27th. The shares were sold at an average price of $128.56, for a total transaction of $128,560.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 69,700 shares of company stock worth $9,375,172. 3.20% of the stock is currently owned by company insiders.

A number of large investors have recently bought and sold shares of ATHN. First Trust Advisors LP bought a new stake in athenahealth in the 2nd quarter valued at $219,000. Legal & General Group Plc boosted its holdings in athenahealth by 11.2% in the 2nd quarter. Legal & General Group Plc now owns 14,358 shares of the health services provider’s stock valued at $2,018,000 after purchasing an additional 1,444 shares during the period. BNP Paribas Arbitrage SA boosted its holdings in athenahealth by 123.8% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock valued at $189,000 after purchasing an additional 744 shares during the period. Prudential Financial Inc. boosted its holdings in athenahealth by 4.9% in the 2nd quarter. Prudential Financial Inc. now owns 2,146 shares of the health services provider’s stock valued at $302,000 after purchasing an additional 100 shares during the period. Finally, Teachers Advisors LLC boosted its holdings in athenahealth by 4.3% in the 2nd quarter. Teachers Advisors LLC now owns 74,015 shares of the health services provider’s stock valued at $10,403,000 after purchasing an additional 3,072 shares during the period.

athenahealth (ATHN) traded down $3.18 during trading on Tuesday, reaching $129.47. 509,300 shares of the company’s stock traded hands, compared to its average volume of 365,211. The firm has a market cap of $5,180.00, a price-to-earnings ratio of 168.14, a PEG ratio of 3.03 and a beta of 1.58. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.35. athenahealth has a 1 year low of $95.01 and a 1 year high of $158.66.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.06. The firm had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.60 EPS. research analysts expect that athenahealth will post 1.22 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “athenahealth, Inc (ATHN) Given Average Recommendation of “Hold” by Brokerages” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/16/athenahealth-inc-athn-given-average-recommendation-of-hold-by-brokerages.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.